Glycomics/Glycobiology Market 2018 Global Share, Trends, Demand, Challenges and Opportunities Research Report Forecast to 2025

Global Glycomics/Glycobiology Market Presents “Global Glycomics/Glycobiology Market Size, Status and Forecast 2018-2025” New Document to its Studies Database. The Report Contain 94 Pages With Detailed Analysis.


This report focuses on the global Glycomics/Glycobiology status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Glycomics/Glycobiology development in United States, Europe and China.

Glycomics is the comprehensive study of glycomes (the entire complement of sugars, whether free or present in more complex molecules of an organism), including genetic, physiologic, pathologic, and other aspects. Glycomics “is the systematic study of all glycan structures of a given cell type or organism” and is a subset of glycobiology. The term glycomics is derived from the chemical prefix for sweetness or a sugar, “glyco-“, and was formed to follow the naming convention established by genomics (which deals with genes) and proteomics (which deals with proteins).


Get sample Report @


Glycobiology is fast emerging as a primary field of interest for biomolecular and biomedical research around the globe. Once considered merely supporting structures, the sugars have now been widely recognized to be a vital component in running the complex machinery of life itself. 

The classification of Glycomics/Glycobiology includes instruments, enzymes, reagents and kits and the proportion of instruments in 2017 is about 34%, and the proportion is in decreasing trend from 2013 to 2017. 

Glycomics/Glycobiology is widely used for drug discovery & development, diagnostics and other feild. The most proportion of Glycomics/Glycobiology is used for drug discovery & development, and the proportion in 2017 is 52.4%. 

North America is the largest consumption place, with a consumption market share nearly 37% in 2017. Following North America, Europe is the second largest consumption place with the consumption market share of 29%. 

In 2017, the global Glycomics/Glycobiology market size was 730 million US$ and it is expected to reach 1730 million US$ by the end of 2025, with a CAGR of 11.5% during 2018-2025.

The key players covered in this study 
ThermoFisher Scientific 
Shimadzu Corporation 
Takara Bio, Inc. 
Agilent Technologies 
Waters Corporation 
R&D Systems 
New England Biolabs 
Merck KGaA

Market segment by Type, the product can be split into 

Market segment by Application, split into 
Drug Discovery & Development 

Market segment by Regions/Countries, this report covers 
United States 
Southeast Asia 
Central & South America


Complete Report Details @


Table of Contents -Major Key Points

1 Report Overview 
1.1 Study Scope 
1.2 Key Market Segments 
1.3 Players Covered 
1.4 Market Analysis by Type 
1.4.1 Global Glycomics/Glycobiology Market Size Growth Rate by Type (2013-2025) 
1.4.2 Instruments 
1.4.3 Enzymes 
1.4.4 Reagents 
1.4.5 Kits 
1.5 Market by Application 
1.5.1 Global Glycomics/Glycobiology Market Share by Application (2013-2025) 
1.5.2 Drug Discovery & Development 
1.5.3 Diagnostics 
1.5.4 Others 
1.6 Study Objectives 
1.7 Years Considered


12 International Players Profiles 
12.1 ThermoFisher Scientific 
12.1.1 ThermoFisher Scientific Company Details 
12.1.2 Company Description and Business Overview 
12.1.3 Glycomics/Glycobiology Introduction 
12.1.4 ThermoFisher Scientific Revenue in Glycomics/Glycobiology Business (2013-2018) 
12.1.5 ThermoFisher Scientific Recent Development 
12.2 Danaher 
12.2.1 Danaher Company Details 
12.2.2 Company Description and Business Overview 
12.2.3 Glycomics/Glycobiology Introduction 
12.2.4 Danaher Revenue in Glycomics/Glycobiology Business (2013-2018) 
12.2.5 Danaher Recent Development 
12.3 Shimadzu Corporation 
12.3.1 Shimadzu Corporation Company Details 
12.3.2 Company Description and Business Overview 
12.3.3 Glycomics/Glycobiology Introduction 
12.3.4 Shimadzu Corporation Revenue in Glycomics/Glycobiology Business (2013-2018) 
12.3.5 Shimadzu Corporation Recent Development 
12.4 ProZyme 
12.4.1 ProZyme Company Details 
12.4.2 Company Description and Business Overview 
12.4.3 Glycomics/Glycobiology Introduction 
12.4.4 ProZyme Revenue in Glycomics/Glycobiology Business (2013-2018) 
12.4.5 ProZyme Recent Development 
12.5 Takara Bio, Inc. 
12.5.1 Takara Bio, Inc. Company Details 
12.5.2 Company Description and Business Overview 
12.5.3 Glycomics/Glycobiology Introduction 
12.5.4 Takara Bio, Inc. Revenue in Glycomics/Glycobiology Business (2013-2018) 
12.5.5 Takara Bio, Inc. Recent Development 
12.6 Agilent Technologies 
12.6.1 Agilent Technologies Company Details 
12.6.2 Company Description and Business Overview 
12.6.3 Glycomics/Glycobiology Introduction 
12.6.4 Agilent Technologies Revenue in Glycomics/Glycobiology Business (2013-2018) 
12.6.5 Agilent Technologies Recent Development 
12.7 Bruker 
12.7.1 Bruker Company Details 
12.7.2 Company Description and Business Overview 
12.7.3 Glycomics/Glycobiology Introduction 
12.7.4 Bruker Revenue in Glycomics/Glycobiology Business (2013-2018) 
12.7.5 Bruker Recent Development 
12.8 Promega 
12.8.1 Promega Company Details 
12.8.2 Company Description and Business Overview 
12.8.3 Glycomics/Glycobiology Introduction 
12.8.4 Promega Revenue in Glycomics/Glycobiology Business (2013-2018) 
12.8.5 Promega Recent Development 




Tags: glycomics glycobiology market, Glycomics/ Glycobiology, Glycomics/ Glycobiology market trend, Glycomics/Glycobiology Market SegmentationSee Campaign:
Contact Information:
NORAH TRENT Partner Relations & Marketing Manager Ph: +1-646-845-9349 (US) Ph: +44 208 133 9349 (UK)             

, Research Newswire, Press Release, Private Equity, Venture Capital, Seed funding, North America, South America, United States, Latin America, United Kingdom, Europe, Africa, Asia, Middle East, English


Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.